Ironwood Pharmaceuticals (IRWD) Change in Receivables (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Change in Receivables data on file, last reported at $59.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 240.31% year-over-year to $59.1 million; the trailing twelve-month figure through Mar 2026 stood at $66.1 million (up 304.88% YoY), and the FY2025 full-year result was -$35.1 million, up 25.59% from the prior year.
• Change in Receivables advanced to $59.1 million in Q1 2026, from -$73.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $59.1 million in Q1 2026 to a low of -$73.6 million in Q4 2025.
• A 5-year average of -$1.9 million and a median of $3.2 million in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables jumped 4405.71% in 2022 and slumped 1395.27% in 2025, its largest moves.
• Tracing IRWD's Change in Receivables over 5 years: stood at -$937000.0 in 2022, then surged by 588.47% to $4.6 million in 2023, then advanced by 24.19% to $5.7 million in 2024, then tumbled by 1395.27% to -$73.6 million in 2025, then soared by 180.27% to $59.1 million in 2026.
• Business Quant data shows IRWD's Change in Receivables at $59.1 million in Q1 2026, -$73.6 million in Q4 2025, and $34.2 million in Q3 2025.